Related topics
| Topic | Replies | Views | Activity | |
|---|---|---|---|---|
| AbbVie to tap Vraylar messaging lessons, but also create a new position to promote key psychiatric drug from Cerevel buy | 2 | 298 | December 8, 2023 | |
| AbbVie (ABBV) Falls 13% After Results for Emraclidine in Schizophrenia Did Not Meet their Primary Endpoint | 3 | 115 | November 11, 2024 | |
| Emraclidine delivers positive results in phase Ib trial | 0 | 188 | December 28, 2023 | |
| AbbVie Revamps Emraclidine Expectations After Mid-Stage Schizophrenia Failure | 0 | 38 | January 31, 2025 | |
| Cerevel says schizophrenia candidate emraclidine doesn't increase blood pressure | 12 | 525 | January 1, 2023 |